L. Sun et al., Effects of XW630 on cell proliferation, iNOS activity, and cGMP content inhuman osteoblast-like cell line TE85, ACT PHAR SI, 21(3), 2000, pp. 261-264
AIM: To study the effects of 2-[3-estrone-N-ethyl-piperazine-methyl] tetrac
ycline (XW630) in human osteoblast-like cell line TE85, METHODS: [H-3]Thymi
dine incorporation and cell count for cell proliferation, radioimmunoassay
for cyclic GMP (cGMP) content, and monitoring the conversion of [H-3]argini
ne for inducible nitric-oxide synthase (iNOS) activity assay. RESULTS: Afte
r treatment with XW630 for 48 h, [H-3]thymidine incorporation and cell numb
ers increased by 62.7% and 96.9%, respectively. N-G-monomethyl-L-arginine (
L-NMMA, an NOS inhibitor) induced a concentration-dependent inhibitory effe
ct on the proliferation after treatment for 48 h. The inhibitory effect was
prevented partially by XW630 (1.0 nmol.L-1). After treatment with XW630 fo
r 12 - 48 h, iNOS activity and cGMP concentration increased in time-depende
nt manners. CONCLUSION: XW630 stimulated cell proliferation, enhanced iNOS
activity and cGMP content in human osteoblast-like cell line TE85.